1 – 10 of 28
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Exploring Definitions and Predictors of Response to Biologics for Severe Asthma
(
- Contribution to journal › Article
-
Mark
Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma
(
- Contribution to journal › Article
- 2023
-
Mark
Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both
(
- Contribution to journal › Article
- 2021
-
Mark
Eosinophilic and Noneosinophilic Asthma : An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort
(
- Contribution to journal › Article
-
Mark
Management of asthma in childhood : Study protocol of a systematic evidence update by the Paediatric Asthma in Real Life (PeARL) Think Tank
(
- Contribution to journal › Article
- 2020
-
Mark
Point-of-care biomarkers in asthma management : Time to move forward
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Research Priorities in Pediatric Asthma : Results of a Global Survey of Multiple Stakeholder Groups by the Pediatric Asthma in Real Life (PeARL) Think Tank
(
- Contribution to journal › Article
-
Mark
International severe asthma registry (ISAR) : protocol for a global registry
(
- Contribution to journal › Article
- 2019
-
Mark
Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
(
- Contribution to journal › Article
-
Mark
The REal Life EVidence AssessmeNt Tool (RELEVANT) : Development of a novel quality assurance asset to rate observational comparative effectiveness research studies
(
- Contribution to journal › Article